In rectal cancer, the type of desmoplastic response after preoperative chemoradiotherapy is associated with prognosis

Virchows Archiv

Volumn 466, Issue 6, 2015, Pages 655-663

  Ueno, Hideki ^a   Shinto, Eiji ^a   Hashiguchi, Yojiro ^b   Shimazaki, Hideyuki ^c   Kajiwara, Yoshiki ^a   Sueyama, Takahiro ^a   Yamamoto, Junji ^a   Hase, Kazuo ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE HOSPITAL   (Japan)

Author keywords

Chemoradiation; Desmoplastic reaction; Fibrotic cancer stroma; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CD8 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CYTOTOXICITY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; RECTUM CARCINOMA; RECTUM SURGERY; REGULATORY T LYMPHOCYTE; RETROSPECTIVE STUDY; TUMOR BIOPSY; VEIN DISEASE; VENOUS INVASION; ADENOCARCINOMA; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECTAL NEOPLASMS;

EID: 84930757774     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-015-1756-1     Document Type: Article

References (37)

1. Bosset J-F, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123
2. Roh MS, Colangelo LH, O'Connell MJ et al (2009) Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 27:5124–5130
3. Gérard J-P, Conroy T, Bonnetain F et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620–4625
4. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemotherapy for rectal cancer. N Engl J Med 351:1731–1740
5. Bouzourene H, Bosman FT, Seelentag W et al (2002) Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 94:1121–1130
6. Suárez J, Vera R, Balén E et al (2007) Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Color Dis 10:563–568
7. Dhadda AS, Dickinson P, Zaitoun AM et al (2011) Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer. Eur J Cancer 47:1138–1145
8. Lee Y-C, Hsieh C-C, Chuang J-P (2013) Prognostic significance of partial tumor regression after preoperative chemoradiotherapy for rectal cancer: a meta-analysis. Dis Colon Rectum 56:1093–1101
9. Kim CW, Yu CS, Yang S-S et al (2011) Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 18:3271–3277
10. Kojima M, Ishii G, Yamane Y et al (2009) Area of residual tumor beyond the muscular layer is a useful predictor of outcome in rectal cancer patients who receive preoperative chemotherapy. Pathol Int 59:857–862
11. Yeo S-G, Kim DY, Kim TH et al (2010) Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg 252:998–1004
12. Persiani R, Biondi A, Gambacorta MA et al (2014) Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer. Br J Surg 101:133–142
13. Ueno H, Jones A, Jass JR et al (2002) Clinicopathological significance of the 'keloid-like' collagen and myxoid stroma in advanced rectal cancer. Histopathology 40:327–334
14. Ueno H, Jones AM, Wilkinson KH et al (2004) Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut 53:581–586
15. Ueno H, Shinto E, Kajiwara Y et al (2014) Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer. Br J Cancer 111:2082–2090
16. Ueno H, Shinto E, Shimazaki H et al. (2014) Histological categorization of desmoplastic reaction: its relevance to the colorectal cancer microenvironment and prognosis. Ann Surg Oncol (Epub ahead of print)
17. Shinto E, Hase K, Hashiguchi Y et al (2014) CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer. Ann Surg Oncol Suppl 3:414–421
18. Tabachnyk M, Distel LV, Büttner M et al (2012) Radiochemotherapy induces a favourable tumour infiltrating inflammatory cell profile in head and neck cancer. Oral Oncol 48:594–601
19. Miyashita M, Sasano H, Tamaki K et al (2014) Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat 148:525–534
20. Shinto E, Hashiguchi Y, Ueno H et al (2011) Pretreatment CD133 and cyclooxygenase-2 expression as the predictive markers of the pathological effect of chemoradiotherapy in rectal cancer patients. Dis Colon Rectum 54:1098–1106
21. Japanese Society for Cancer of the Colon and Rectum (2009) Japanese classification of colorectal carcinoma (second English edition). Kanehara & Co., Ltd, Tokyo
22. Kim TH, Chang HJ, Kim DY et al (2009) Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Int J Radiat Oncol 77:1158–1165
23. Tsai CJ, Crane CH, Skibber JM et al (2011) Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer 117:3713–3722
24. Lee JH, Jang HS, Kim J-G et al (2012) Lymphovascular invasion is a significant prognosticator in rectal cancer patients who received preoperative chemoradiotherapy followed by total mesorectal excision. Ann Surg Oncol 19:1213–1221
25. Trakarnsanga A, Gonen M, Shia J et al (2013) What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy? Ann Surg Oncol 20:1179–1184
26. Perez RO, São Julião GP, Habr-Gama A et al (2009) The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer. Dis Colon Rectum 52:1137–1143
27. Jass JR (1986) Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol 39:585–589
28. Ropponen KM, Eskelinen MJ, Lipponen PK et al (1997) Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182:318–324
29. Mei Z, Liu Y, Liu C et al (2014) Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis. Br J Cancer 110:1595–1605
30. Shia J, Guillem JG, Moore HG et al (2004) Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 28:215–223
31. Lieubeau B, Heymann M, Henry F et al (1999) Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int J Cancer 81:629–636
32. Chargari C, Clemenson C, Martins I et al (2013) Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulation. Drug Resist Updat 16:10–21
33. Hodkinson PS, Mackinnon AC, Sethi T (2007) Extracellular matrix regulation of drug resistance in small-cell lung cancer. Int J Radiat Biol 83:733–741
34. Allen M, Louise Jones J (2011) Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 223:162–176
35. Baumann M, Krause M, Hill R (2008) Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 8:545–554
36. Radisky DC, LaBarge MA (2008) Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell 2:511–412
37. Ashley N (2013) Regulation of intestinal cancer stem cells. Cancer Lett 38:120–126